Sitagliptin in Renal Transplant Recipients

NCT00740363 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Glucose Intolerance

Interventions

DRUG: sitagliptin
DRUG: placebo

Sponsor

University of Oslo School of Pharmacy

Collaborators

[object Object]